NSE close · Thu, 1 OctNifty 5022,421.95▼ 0.88%Nifty Bank54,450.75▼ 0.33%Midcap 10058,732.00▼ 1.01%Smallcap 25017,589.05▼ 1.18%India VIX14.46▲ 7.19%IT28,304.70▲ 2.17%Auto25,384.95▼ 3.46%Pharma26,311.55▼ 0.48%FMCG43,789.85▼ 1.61%Metal12,460.70▼ 2.35%Realty835.00▼ 1.46%Energy36,388.15▼ 0.68%PSU Bank7,937.80▼ 0.98%Financials24,556.10▼ 0.38%Media1,546.30▼ 2.33%Defence9,142.55▼ 1.45%Durables35,927.80▼ 1.91%Biggest movesMONEYVIEW▲ 58.5%MOLBIO▲ 15.6%THOMASCOTT▲ 12.3%AUGMONT▲ 10.0%HEROMOTORS▲ 10.0%VIVIANA▲ 10.0%LOKESHMACH▲ 9.5%ANAWIL▼ 11.0%

Top stories

Broker call + Pharma and healthcare · 1 storyClear filters

Developing 71 Picking up 6 Price moves 3 Following

Busiest tags today

AI76 Crude oil48 Bond yields43 Global markets37 Banks36 Geopolitics36 Trade and tariffs34 US jobs data34 Jobs and layoffs32 Inflation30 Wall Street27 Donald Trump26 Autos23 RBI22 Every tag in Market pulse →

Topic

Pharma and healthcare▼ −25% net tone today

16 stories today · 193 since 24 SeptNifty Pharma −0.48% vs Nifty −0.88% on Thu, 1 Oct

Granules India incorporated Triton Farmaceutica Do Brasil Ltda as a wholly owned subsidiary in Brazil
Global Health acquired land in Ghaziabad for a planned Medanta hospital
Maharashtra FDA cancelled Cipla Pharma’s Pune warehouse distribution licences over serious violations

Often with, this weekHospitals39 Apollo Hospitals16 Sun Pharma13 USFDA10 Supreme Court9

Open tag page →Clear ×

Stories per day

527 Sept

3528 Sept

3829 Sept

3030 Sept

291 Oct

152 Oct

23 Oct

Broker call▼

Jefferies is bullish on 6 healthcare stocks with upside potential of up to 46%. Own any?

Hospital stocks extended losses amid scrutiny over cancer-drug markups and pharmacy practices
Jefferies maintained Buy ratings on six healthcare stocks, with potential upside of up to 46%
Regulatory scrutiny pressures hospital stocks, while Jefferies’ calls may support Indian healthcare sentiment

Hospitals Pharma and healthcare Jefferies1 source · 1d

That’s everything for today